Literature DB >> 28452342

Air kerma calculation in Monte Carlo simulations for deriving normalized glandular dose coefficients in mammography.

Antonio Sarno1, Giovanni Mettivier, Paolo Russo.   

Abstract

The estimation of the mean glandular dose in mammography using Monte Carlo simulations requires the calculation of the incident air kerma evaluated on the breast surface. In such a calculation, caution should be applied in considering explicitly the presence of the top compression paddle, since Compton scattering in this slab may produce a large spread of the incidence angles of x-ray photons on the scoring surface. Then, the calculation of the incident air kerma should contain the 'effective' area of the scoring surface, which takes into account the angle of incidence of photons on such a surface. Using Geant4 Monte Carlo simulations with a code previously validated according to the Task Group 195 of the American Association of Physicists in Medicine, we show that for typical x-ray spectra and energy range adopted in mammography, the resulting discrepancy in the calculation of the incident air kerma may lead to an overestimation from a minimum of 10% up to 12% of normalized dose coefficients and, hence, of the corresponding mean glandular dose if this contribution is not considered.

Entities:  

Mesh:

Year:  2017        PMID: 28452342     DOI: 10.1088/1361-6560/aa7016

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  2 in total

1.  Internal breast dosimetry in mammography: Monte Carlo validation in homogeneous and anthropomorphic breast phantoms with a clinical mammography system.

Authors:  Christian Fedon; Marco Caballo; Ioannis Sechopoulos
Journal:  Med Phys       Date:  2018-06-29       Impact factor: 4.071

2.  Three-layer heterogeneous mammographic phantoms for Monte Carlo simulation of normalized glandular dose coefficients in mammography.

Authors:  Tien-Yu Chang; Kuan-Jen Lai; Chun-Yuan Tu; Jay Wu
Journal:  Sci Rep       Date:  2020-02-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.